Elyxium Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.3M Buy
6,087
+4,435
+268% +$4.53M 0.77% 30
2026
Q1
$1.52M Buy
1,652
+132
+9% +$134K 0.49% 51
2025
Q4
$1.63M Buy
1,520
+25
+2% +$23.9K 0.45% 46
2025
Q3
$1.14M Sell
1,495
-337
-18% -$251K 0.4% 55
2025
Q2
$1.43M Buy
1,832
+122
+7% +$94.8K 0.54% 45
2025
Q1
$1.41M Buy
1,710
+1,177
+221% +$979K 0.63% 39
2024
Q4
$411K Sell
533
-752
-59% -$623K 0.25% 57
2024
Q3
$1.14M Buy
+1,285
New +$1.16M 0.63% 38

Other funds holding LLY

Elyxium Wealth's LLY Position: Q2 2026 in Review

Elyxium Wealth increased its Eli Lilly (LLY) stake by 268% in Q2 2026, buying an estimated $4.53M and bringing the position to 6,087 shares worth $7.3M. The position accounts for 0.77% of the portfolio, ranked #30.

Elyxium Wealth first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elyxium Wealth held 6,087 shares of Eli Lilly worth $7.3M as of Q2 2026.
  • Elyxium Wealth bought 4,435 Eli Lilly shares in Q2 2026, an estimated $4.53M.
  • Eli Lilly made up 0.77% of Elyxium Wealth's portfolio in Q2 2026, its #30 holding.
  • Elyxium Wealth first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.